B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

Benzinga · 1d ago
B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $40 to $70.